JONSSON PATRIK (SVP and Pres., Lilly Bio-Meds) sold 10.7% of their position (6.50K shares) of ELI LILLY & CO on the open market
Open‑market sale worth $7.64M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2026ACC: 0001786054-26-000006
Officer· SVP and Pres., Lilly Bio-Meds
Since Sep 2019
-6.50K
Net shares
Net seller
$7.64M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.50K
Price / share
$1.18K
Trade value
$7.64M
% of position
10.7%
8/17/2026
60.65K→54.15K
Total
Net shares
−6.50K
Net value
-$7.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | S · Sale | −6.50K | $1.18K | $7.64M | 10.7% | 60.65K | 54.15K |
| Total | −6.50K | -$7.64M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned632.40
Total
632.40 indirect632.40
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 632.40 | Indirect |
| Total | 632.40 | 632.40 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported